Swarup Dey
Principal Scientist Regeneron Pharmaceuticals
Seminars
Wednesday 2nd December 2026
Platform approach for AAV analytics
12:00 pm
- Defining what constitutes a platform analytical method in AAV programs and identifying which assays and attributes can realistically be leveraged across products
- Establishing phase-appropriate strategies for applying platform methods, with clear expectations for method development, qualification, and validation as programs advance
- Creating practical criteria for method reuse, redevelopment, and revalidation to reduce redundant validation efforts and enable efficient, scalable analytical approaches across similar AAV therapies
